2018 Belgian guidelines for the screening for latent tuberculosis in HIV-infected patients
Chloé Wyndham-Thomas(Université Libre de Bruxelles), Jean‐Paul Van Vooren(Université Libre de Bruxelles), Maryse Wanlin, Jean‐Christophe Goffard(Université Libre de Bruxelles), Violette Dirix(Université Libre de Bruxelles), Françoise Mascart(Université Libre de Bruxelles), Sophie Henrard(Université Libre de Bruxelles), Steven Callens(Ghent University Hospital)
Cited by 4
Related Papers
Immunogenicity and protective efficacy of a tuberculosis DNA vaccine
|Nature Medicine|1996|632
Deep Dermatophytosis and Inherited CARD9 Deficiency
|New England Journal of Medicine|2013|403
Unspecific post-mortem findings despite multiorgan viral spread in COVID-19 patients
|Critical Care|2020|302
Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations
|Journal of Allergy and Clinical Immunology|2021|175
Methylation-dependent T cell immunity to Mycobacterium tuberculosis heparin-binding hemagglutinin
|Nature Medicine|2004|144